Anti-Testosterone, Recombinant [3T16]
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (1)
- Inventor Info
Info
| Catalogue Number | 153259 |
| Applications | ELISA RIA |
| Antigen/Gene or Protein Targets | Testosterone-3-(O-carboxymethyl)oxime) |
| Reactivity | Human |
| Relevance | Testosterone is the major androgen steroid hormone and has a role in reproduction and the development of male secondary sex characteristics. 3T16 can be used for detecting and measuring testosterone levels in serum and tissue. |
| Host | Mouse |
| Immunogen | Testosterone-3-(O-carboxymethyl)oxime coupled to bovine serum albumin |
| Subclass | IgG1 |
| Formulation | PBS |
| Concentration | 1mgml-1 |
| Research Area | Developmental Biology |
| Notes |
Recombinant monoclonal antibody produced from the original monoclonal cell line. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma. Eight products based on this clone: - Anti-Testosterone [3T16], Mouse IgG1, Kappa - Anti-Testosterone [3T16], Rabbit IgG, Kappa - Anti-Testosterone [3T16], Human IgG4-S228P, Kappa - Anti-Testosterone [3T16], Human IgG1, Kappa - Anti-Testosterone [3T16], Human IgG1, Kappa, engineered Fc domain containing key point mutations that abrogate binding to Fc gamma receptors - Anti-Testosterone [3T16], Rat IgG1, Kappa - Anti-Testosterone [3T16], Rat IgG2b, Kappa - Anti-Testosterone [3T16], Rat IgG2b, Kappa, engineered Fc domain containing key point mutations that abrogate binding to Fc gamma receptors |
References: 1 entry
Original hybridoma first published in: Fantl et al. 1983. J Steroid Biochem. 19(5):1605-10. PMID: 6645496.
Add a reference
References: 1 entry
Original hybridoma first published in: Fantl et al. 1983. J Steroid Biochem. 19(5):1605-10. PMID: 6645496.
Add a reference
